Table 2: Immunosuppressive and pain medication of Middle-European RA-patients to COMORA-data. Data are given in absolute numbers (% in brackets).
bDMARD, biological disease-modifying antirheumatic drug (DMARD), csDMARD, conventional synthetic DMARD; MTX, methotrexate; n.a., not available; NSAIDs, non-steroidal antirheumatic drugs; p<0.01, highly significant (using chi²-test for comparison with Middle-European cohort).

Medication	Middle-European	COMORA Austria	COMORA
NSAIDs (%)	43 (53.8)	102 (50)	2156 (55)
Glucocorticoids (%)	23 (28.8)	65 (32)	2117 (54)***
MTX (%)	75 (93.8)	192 (94)	3489 (89)
bDMARDs (% ever treated)	29 (36.3)	120 (59)***	1529 (39)
- bDMARDs with csDMARDs (%)	23 (28.8)	n.a.	n.a.
- bDMARDs without csDMARD (%)	2 (2.5)	n.a.	n.a.
- TNF-inhibitor without csDMARD (%)	0 (0)	n.a.	n.a.